The Genetic Basis of Renal Cell Carcinoma
Overview
Affiliations
The recognition of hereditary forms of renal cancer and the development of high-throughput genetic analysis have led to the identification of genes responsible for familial renal epithelial tumors of differing histologies and cytogenetic features. Some of these genes (VHL) are known to have an important role in sporadic renal neoplasia. This article describes the various epithelial renal tumors most commonly encountered by the urologist, the molecular and cytogenetic distinctions between them, and the hereditary syndromes that predispose to these tumors. Consideration of these syndromes is important for proper treatment when one encounters patients with multiple renal tumors, tumors at an early age of onset, or patients with a positive family history of renal cell carcinoma.
Alchahin A, Tsea I, Baryawno N Cancers (Basel). 2023; 15(19).
PMID: 37835428 PMC: 10571653. DOI: 10.3390/cancers15194734.
Use of Circular RNAs in Diagnosis, Prognosis and Therapeutics of Renal Cell Carcinoma.
Osca-Verdegal R, Beltran-Garcia J, Gorriz J, Jabaloyas J, Pallardo F, Garcia-Gimenez J Front Cell Dev Biol. 2022; 10:879814.
PMID: 35813211 PMC: 9257016. DOI: 10.3389/fcell.2022.879814.
RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma.
Yu S, Dai J, Ma M, Xu T, Kong Y, Cui C Cell Death Dis. 2019; 10(4):254.
PMID: 30874541 PMC: 6420644. DOI: 10.1038/s41419-019-1488-2.
Renal Cell Carcinoma: Molecular Aspects.
Kumar A, Kumari N, Gupta V, Prasad R Indian J Clin Biochem. 2018; 33(3):246-254.
PMID: 30072823 PMC: 6052717. DOI: 10.1007/s12291-017-0713-y.
Dmitriev A, Rudenko E, Kudryavtseva A, Krasnov G, Gordiyuk V, Melnikova N Biomed Res Int. 2014; 2014:735292.
PMID: 24977159 PMC: 4054851. DOI: 10.1155/2014/735292.